SCHEMBL21026345

SCHEMBL21026345

CCc1ccc(S(=O)(=O)N[C@@H](C)C(F)(F)F)cc1OC(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RORC P51449 5/20 0.42
ALDH1A1 P00352 2/20 0.39
HRH4 Q9H3N8 1/20 0.37
KMT2A Q03164 2/20 0.35
FFAR4 Q5NUL3 1/20 0.35
CNR2 P34972 2/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
S100A9 P06702 1/20 0.34
NMT1 P30419 1/20 0.34
MEN1 O00255 1/20 0.34
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21028344 0.86 ALDH1A1 (0.39) RORCALDH1A1KMT2ACA1CA2
SCHEMBL21028122 0.85 RORC (0.41) RORCALDH1A1HRH4KMT2AFFAR4
SCHEMBL16852355 0.84 FFAR4 (0.42) RORCALDH1A1KMT2AFFAR4S100A9
SCHEMBL21028211 0.83 RORC (0.41) RORCALDH1A1HRH4KMT2AFFAR4
SCHEMBL17709877 0.83 ALDH1A1 (0.43) RORCALDH1A1KMT2AFFAR4CNR2
SCHEMBL17709875 0.83 ALDH1A1 (0.43) RORCALDH1A1KMT2AFFAR4CNR2
SCHEMBL21028141 0.80 RORC (0.42) RORCKMT2AFFAR4CA1CA2
SCHEMBL21028377 0.77 RORC (0.41) RORCCA1CA2MAPK1LMNA
SCHEMBL17709811 0.73 ALDH1A1 (0.47) RORCALDH1A1HRH4KMT2AFFAR4
SCHEMBL29509411 0.73 ALDH1A1 (0.47) RORCALDH1A1HRH4KMT2AFFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10301272-B2 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] PHENEX PHARMACEUTICALS AG (DE) 2019-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10301272-B2 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] RORA, RORB, RORC RORC 3/4885ALDH1A1 671/4885HRH4 482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.